5
Introduction
Vivo 40 clinician’s manual
Doc. 003886 En-Us A-1e
The Vivo 40 is intended to be operated by qualified and trained personnel.
The Vivo 40 is intended for use in clinical settings (e.g., hospitals, sleep labora-
tories, sub-acute care institutions) and home environments. The Vivo 40 must
always be prescribed by a licensed physician.
The CPAP function is intended to deliver continuous positive airway pressure
therapy for the treatment of obstructive sleep apnea, via non-invasive nasal or
full-face masks.
1.3 Contraindications
The use of the Vivo 40 is contraindicated on patients with severe respiratory
failure without a spontaneous respiratory drive.
The use of the Vivo 40 for positive pressure therapy may be contraindicated on
patients:
• Incapable of maintaining life- sustaining ventilation in the event of a brief
circuit disconnection or loss of therapy.
• Unable to maintain a patent airway or adequately clear secretions.
• At risk for aspiration of gastric contents.
• With a history of allergy or hypersensitivity to the mask materials where the
risk from allergic reaction outweighs the benefit of ventilatory assistance.
Therapy with the Vivo 40 should
not
be prescribed when the following specific
diseases or conditions are present:
• Bullous lung disease
• Pathologically low blood pressure
• Severe cardiac arrhythmias
• Coronary artery disease
• Unstable angina pectoris
• Decompensated cardiac failure or hypotension, particularly if associated
with intravascular volume depletion
• Recent thoracic surgery
• Pneumothorax
• Pneumomediastinum
